LRRC32 and lung carcinoma: The proportion of GARP+ cells reached 65.80 ± 4.149% and 34.73 ± 2.578%, which were far higher than that in other lung cancer cell lines coculture assays, whereas that in the positive control was 83.60 ± 5.453% (Figures 3C,D).